Mutational landscape and response are conserved in peripheral blood of AML and MDS patients during decitabine therapy

類似資料

• Dynamic Changes in the Clonal Structure of MDS and AML in Response to Epigenetic Therapy
  著者:: Uy, Geoffrey L., 等
  出版事項: (2016)
• A phase I dose escalation study of oral bexarotene in combination with intravenous decitabine in patients with AML
  著者:: Welch, John S., 等
  出版事項: (2014)
• Subclones dominate at MDS progression following allogeneic hematopoietic cell transplant
  著者:: Jacoby, Meagan A., 等
  出版事項: (2018)
• TP53 and Decitabine in Acute Myeloid Leukemia and Myelodysplastic Syndromes
  著者:: Welch, John S., 等
  出版事項: (2016)
• Immune Escape of Relapsed AML Cells after Allogeneic Transplantation
  著者:: Christopher, Matthew J., 等
  出版事項: (2018)